Active Surveillance for Low-Risk Cancer—The Waiting Is the Hardest Part-Reference-Cited by-同舟云学术

Active Surveillance for Low-Risk Cancer—The Waiting Is the Hardest Part

Published:2024-08-15 Issue: Volume: Page:
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Haggstrom David A.¹²,Braafladt Signe M.³⁴,Han Paul K. J.⁵

Affiliation:

1. VA Health Systems Research Center for Health Information and Communication, Indianapolis VA Medical Center, Indianapolis, Indiana

2. Division of General Internal Medicine & Geriatrics, Department of Medicine, Indiana University School of Medicine, Indianapolis

3. Center for Health Services Research, Regenstrief Institute, Indianapolis, Indiana

4. Department of Surgery, Indiana University School of Medicine, Indianapolis

5. Behavioral Research Program, National Cancer Institute, Bethesda, Maryland

Abstract

This Viewpoint describes the benefits and challenges of active surveillance as a clinical approach to monitor low-risk cancers with favorable prognoses.

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2822320/jamaoncology_haggstrom_2024_vp_240018_1722968192.03579.pdf

Reference10 articles.

1. Follow-up of prostatectomy versus observation for early prostate cancer.;Wilt;N Engl J Med,2017

2. An observational trial for papillary thyroid microcarcinoma in Japanese patients.;Ito;World J Surg,2010

3. Breast cancer screening: women’s experiences of waiting for further testing.;Pineault;Oncol Nurs Forum,2007

4. Scanxiety: a scoping review about scan-associated anxiety.;Bui;BMJ Open,2021

5. Acceptance and commitment therapy for symptom interference in metastatic breast cancer patients: a pilot randomized trial.;Mosher;Support Care Cancer,2018